Revelation Biosciences In... (REVB)
NASDAQ: REVB
· Real-Time Price · USD
2.56
-0.02 (-0.78%)
At close: Aug 15, 2025, 11:28 AM
Revelation Biosciences Fail-to-Deliver
Total FTD Shares
1K
Below Average
FTD / Avg. Volume
0.22%
Low Impact
1-Year Change
-90.2%
Negative Trend
FTD Chart
As of Jul 14, 2025,
Revelation Biosciences Inc. has
1,003
shares failed to deliver, representing 0.22%
of the average daily volume of
457,343
shares. Over the past year, the monthly average FTD is
30,352
shares, with the current level 97% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
Date | Price | FTD Shares | % Change |
---|---|---|---|
Jul 14, 2025 | 2.75 | 1K | -90.89% |
Jun 27, 2025 | 2.28 | 11.01K | -92.16% |
May 30, 2025 | 2.55 | 140.51K | +5623.38% |
Apr 30, 2025 | 9.15 | 2.46K | +1558.78% |
Mar 27, 2025 | 8.28 | 148 | +164.29% |
Feb 28, 2025 | 10.47 | 56 | -98.55% |
Jan 31, 2025 | 11.31 | 3.87K | -89.39% |
Dec 30, 2024 | 18.48 | 36.49K | -17.36% |
Nov 29, 2024 | 36.48 | 44.16K | +5232.97% |
Oct 31, 2024 | 40.94 | 828 | -96.00% |
Sep 30, 2024 | 40.89 | 20.69K | +196.21% |
Aug 30, 2024 | 55.2 | 6.98K | +80.84% |
Jul 24, 2024 | 79.2 | 3.86K | +105.64% |
Jun 27, 2024 | 89.28 | 1.88K | +2.68% |
May 31, 2024 | 92.64 | 1.83K | +449.25% |
Apr 23, 2024 | 99.36 | 333 | -78.42% |
Mar 28, 2024 | 131.52 | 1.54K | -61.80% |
Feb 29, 2024 | 175.2 | 4.04K | -95.63% |
Jan 31, 2024 | 422.4 | 92.52K | +27353.41% |
Dec 29, 2023 | 721.01 | 337 | -93.63% |
Nov 30, 2023 | 1041.26 | 5.29K | +19.89% |
Oct 27, 2023 | 831.46 | 4.41K | -29.76% |
Sep 14, 2023 | 1080 | 6.28K | +240.41% |
Aug 09, 2023 | 1106.5 | 1.85K | -88.78% |
Jul 24, 2023 | 1147.68 | 16.46K | +66.97% |
Jun 20, 2023 | 1508.98 | 9.86K | -67.94% |
May 30, 2023 | 1497.6 | 30.75K | -33.40% |
Apr 28, 2023 | 1555.2 | 46.17K | +351.92% |
Mar 31, 2023 | 1872 | 10.22K | +252.64% |
Feb 28, 2023 | 3211.2 | 2.9K | -76.52% |
Jan 31, 2023 | 15119.98 | 12.34K | n/a |